Researcher comment: Apalutamide addition improves metastatic CSPC survival | Axel Merseburger Medicine Matters oncology 3:04 5 years ago 249 Далее Скачать
Axel Merseburger, ESMO 2019 - Advances in metastatic hormone-sensitive prostate cancer Touch Medical Media 4:40 5 years ago 645 Далее Скачать
Apalutamide Plus ADT Leads to Survival Benefit in mCSPC Targeted Oncology 1:28 5 years ago 244 Далее Скачать
Live from ASCO: Apalutamide for Castration-Sensitive Prostate Cancer NEJM Group 2:50 5 years ago 2 544 Далее Скачать
TITAN Trial | Investigating the addition of apalutamide to androgen deprivation therapy Prostate Cancer Foundation of Australia 31:13 10 months ago 915 Далее Скачать
Support for continuing enzalutamide after mCRPC progression | Axel Merseburger Medicine Matters oncology 4:35 2 years ago 282 Далее Скачать
High risk prostate cancer and mHSPC | With Axel Merseburger GU Cast 26:49 9 months ago 686 Далее Скачать
Apalutamide in Metastatic Castration-Sensitive Prostate Cancer (mCSPC): A Case-Based Discussion AmerUrological 34:48 2 months ago 57 Далее Скачать
Dr. Agarwal on the QoL With Apalutamide in Metastatic Castration-Sensitive Prostate Cancer OncLive 1:46 5 years ago 122 Далее Скачать
Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU ... ecancer 17:49 3 years ago 703 Далее Скачать
Managing AEs in Metastatic CSPC: TROPIC and CARD Trials Targeted Oncology 2:01 4 years ago 19 Далее Скачать
EAU15: Merseburger and Meitland about Differing Perspectives on Anti-Androgen Therapy European Association of Urology 7:04 9 years ago 42 Далее Скачать
The Evolving Treatment Landscape of Prostate Cancer Targeted Oncology 1:57 5 years ago 319 Далее Скачать
